4.5 Review

The bromodomain interaction module

期刊

FEBS LETTERS
卷 586, 期 17, 页码 2692-2704

出版社

WILEY
DOI: 10.1016/j.febslet.2012.04.045

关键词

Bromodomain; Lysine acetylation; Sequence specificity

资金

  1. Canadian Institutes for Health Research [1097737]
  2. Canada Foundation for Innovation
  3. Genome Canada
  4. GlaxoSmithKline
  5. Pfizer
  6. Eli Lilly
  7. Novartis Research Foundation
  8. Ontario Ministry of Research and Innovation
  9. Wellcome Trust
  10. Wellcome Trust [095751/Z/11/Z]
  11. Wellcome Trust [095751/Z/11/Z] Funding Source: Wellcome Trust

向作者/读者索取更多资源

epsilon-N-acetylation of lysine residues (K-ac) is one of the most abundant post-translation modifications (PTMs) in the human proteome. In the nucleus, acetylation of histones has been linked to transcriptional activation of genes but the functional consequences of most acetylation events and proteins recruited to these sites remains largely unknown. Bromodomains (BRDs) are small helical interaction modules that specifically recognize acetylation sites in proteins. BRDs have recently emerged as interesting targets for the development of specific protein interaction inhibitors, enabling a novel exiting strategy for the development of new therapies. This review provides an overview over sequence requirements of BRDs, known substrates and the structural mechanisms of specific K-ac recognition. (C) 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据